Richard J. Havel, Robert L. Hamilton – 1 November 1988

Kwang‐Juei Lo, Shou‐Dong Lee, Yang‐Te Tsai, Tzee‐Chung Wu, Cho‐Yu Chan, Gran‐Hum Chen, Ching‐Lan Yeh – 1 November 1988 – In an attempt to evaluate the long‐term immunogenicity and efficacy of plasma‐derived hepatitis B vaccine in preventing hepatitis B virus infection, 199 infants born to hepatitis B e antigen‐positive hepatitis B surface antigen‐carrier mothers were found to be antibody to HBsAg‐positive (± 10 mIU per ml) 2 months after the first booster of hepatitis B vaccination at age 1, and their serum HBsAg and anti‐HBs were rechecked annually to ages 3 to 5.

Antonio Ponzetto, Francesco Negro, Hans Popper, Ferruccio Bonino, Ronald Engle, Mario Rizzetto, Robert H. Purcell, John L. Gerin – 1 November 1988 – Five consecutive passages of hepatitis delta virus in hepatitis B virus carrier chimpanzees were performed in order to further characterize the infectious and pathogenic nature of this naturally occurring defective virus. Three animals received identical inocula at fourth passage in order to assess individual animal variation as a factor in the course of infection and disease.

Geoffrey M. Dusheiko – 1 November 1988 – In a previous study a partial inhibition of viral replication was observed in HBeAg‐positive patients after acyclovir (ACV) treatment.

Hastings K. Wright – 1 November 1988

Guido Piai, Livio Cipolletta, Max Claar, Giampiero Marone, Maria Antonietta Bianco, Giovanni Forte, Giuseppe Iodice, Daniele Mattera, Mauro Minieri, Pietro Rocco, Lorenzo Michele Santoro, Gabriele Mazzacca – 1 November 1988 – In this prospective, multicenter trial, 140 cirrhotic patients with no previous upper gastrointestinal bleeding and with esophageal varices endoscopically judged to be at high risk of hemorrhage were randomized to receive either sclerotherapy or conservative treatment for the prevention of first variceal bleeding. The end‐points of the study were bleeding and death.

Erica Villa, Grazia M. Baldini, Gian Paolo Rossini, Claudio Pasquinelli, Margherita Melegari, Elisabetta Cariani, Cristina Tata, Stefano Bellentani, Alberto Ferrari, Federico Manenti – 1 November 1988 – The hepatic cytosolic estrogen receptor content was measured in liver samples from patients with normal livers and from patients with nonalcoholic cirrhosis, alcoholic cirrhosis and alcoholic hepatitis. The estrogen receptor content of normal liver was 5.2 ± 3.5 fmoles per mg of cytosolic protein.

Philippe Mavier, Bernard Guigui, Anne‐Marie Preaux, Jean Rosenbaum, Marie‐Claude Lescs, Elie Serge Zafrani, Daniel Dhumeaux – 1 November 1988 – Hydrogen peroxide produced by stimulated phagocytic cells or during the metabolism of drugs, is toxic to various cell types. The aim of this study was to investigate its toxicity against normal vs. tumor rat hepatocytes.

Leonard B. Seeff – 1 November 1988 – The authors tested, by molecular hybridization, for hepatitis B virus DNA in serum specimens of 182 asymptomatic hepatitis B surface antigen (HBsAg) Greek carriers who were heterosexual partners of patients with acute hepatitis B (group A: 96 cases) or healthy subjects who were susceptible to hepatitis B (group B: 86 cases). The mean age (34.1 ± 10.4 vs. 33.9 ± 8.4 years) and the mean duration of sexual contact (6.9 ± 8.9 vs. 7.2 ± 6.3 years) were similar in the two groups of carriers.

Akio Shimizu, Kazuo Tarao, Shouji Takemiya, Masaoki Harada, Tohru Inoue, Tetsuo Ono – 1 November 1988 – Using a monoclonal antibody to bromodeoxyuridine, we studied the cell kinetics of human hepatocellular carcinoma, liver cirrhosis, chronic active hepatitis and alcoholic liver fibrosis. Specimens were taken either by biopsy or surgery and immediately incubated with 0.1% bromodeoxyuridine solution at 37°C for 45 min.